MONTREAL, Nov. 17, 2016 -- Ropack Pharma Solutions announces it will launch an international serialization hub as a practical solution for pharmaceutical organizations and contract packaging partners that are not serialization-ready by the Drug Supply Chain Security Act (DSCSA) mandated deadline.
Through the serialization hub, packaged pharmaceutical products are sent by an organization’s in-house packaging team or contract partners to Ropack’s Montreal facility. There the packaged products are serialized as required – to the product, the carton or the palette. The serialized product is then shipped, as directed, to a distribution network in the U.S. or Canada, a warehouse for aggregation with other orders or to international destinations which have already adopted serialization.
“Our serialization hub is an efficient alternative,” notes Paul Dupont, Ropack’s VP of Marketing and Business Development. “Becoming serialization-ready is a complex, time-consuming and expensive undertaking which is not practical for every company.” Dupont points out that his company’s serialization hub reduces an organization’s capital expenditures, need for increased personnel and the multifaceted coordination serialization requires.
“A significant benefit is that pharma companies can continue to use their trusted contract packagers – or in-house team – then outsource the serialization component to Ropack.”
According to Dupont, an added benefit is that international shipping from Canada is significantly easier than from the U.S.
Ropack Pharma Solutions (RPS) brings solid oral dosage packaging solutions to leading pharmaceutical and natural health organizations: bottle, flip-top vial, blister (cold formed and thermoformed), stick-packs, sachets, strip-packs. RPS's International Serialization Hub will provide a practical solution for organizations not serialization-ready by November 2017. Headquartered in Montreal, RPS offers the highest level of quality along with gold-standard technology and a responsive, cross-trained staff. Since 1976.
Contact: Paul Dupont, VP Marketing and Business Development Ropack, Inc. [email protected] 513.846.0921


California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 



